ArticleTranslational lung cancer research2025
Factors predicting early recurrence in patients with unresectable stage III non-small cell lung cancer on durvalumab consolidation after chemoradiotherapy.
Ji Eun Park et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.